Andrew Reaume
Chief Executive Officer at Melior Discovery, Inc.
Andrew Reaume active positions
| Companies | Position | Start | End |
|---|---|---|---|
Melior Discovery, Inc.
 Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Chief Executive Officer | 2004-12-31 | - |
| Founder | 2004-12-31 | - | |
| President | 2004-12-31 | - | |
Melior Pharmaceuticals I, Inc.
 Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Melior Pharmaceuticals I, Inc. operates as a clinical stage pharmaceutical company. The private company is based in Exton, PA. The company was founded in 2008 by Andrew G Reaume. | President | 2008-11-30 | - |
| Founder | 2008-11-30 | - | |
| Chief Executive Officer | 2008-11-30 | - |
Career history of Andrew Reaume
Former positions of Andrew Reaume
| Companies | Position | Start | End |
|---|---|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 1992-12-31 | 1998-12-31 |
| ADHERA THERAPEUTICS, INC. | Director/Board Member | 2021-09-08 | - |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Training of Andrew Reaume
| University of Connecticut | Doctorate Degree |
| University of Pennsylvania | Masters Business Admin |
Statistics
International
| United States | 8 |
Operational
| Chief Executive Officer | 3 |
| Founder | 3 |
| President | 3 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Commercial Services |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Melior Pharmaceuticals I, Inc.
Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Melior Pharmaceuticals I, Inc. operates as a clinical stage pharmaceutical company. The private company is based in Exton, PA. The company was founded in 2008 by Andrew G Reaume. | Health Technology |
- Stock Market
- Insiders
- Andrew Reaume
- Experience
